Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.8400
-0.0499-5.61%
Volume:71.46K
Turnover:62.28K
Market Cap:22.39M
PE:-2.94
High:0.9098
Open:0.8982
Low:0.8400
Close:0.8899
52wk High:3.40
52wk Low:0.8208
Shares:26.65M
Float Shares:21.83M
Volume Ratio:0.73
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.18
PE(LYR):-2.14

Loading ...

Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics

Dow Jones
·
May 12

Yukiguni Maitake Sees FY Net Y2.54B

Dow Jones
·
May 11

Press Release: Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Dow Jones
·
May 07

Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

TIPRANKS
·
May 07

Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD

TIPRANKS
·
May 04

Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility

TIPRANKS
·
May 02

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 30

Humanwell Healthcare Subsidiary Gets China Nod for ADHD Treatment

MT Newswires Live
·
Apr 09

ABVC BioPharma Shareholders Back Board, Equity Plan Changes

TIPRANKS
·
Mar 28

ABVC Biopharma held annual shareholder meeting; quorum reached with 10.6 million shares represented by proxy

Reuters
·
Mar 28

Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 27

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

GlobeNewswire
·
Mar 26

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

TIPRANKS
·
Mar 20

Press Release: Collegium to Acquire AZSTARYS(R) from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Dow Jones
·
Mar 19

Press Release: Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Dow Jones
·
Mar 18

ABVC posts FY 2025 net loss of USD 8.4 million (59% increase)

Reuters
·
Mar 04

Abvc Biopharma Says Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon; Reports Material Weakness In Internal Controls Over Financial Reporting For FY25

Benzinga Earnings
·
Mar 04

BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon

Reuters
·
Mar 04

ABVC Biopharma Inc - Reports Material Weakness in Internal Controls Over Financial Reporting for FY2025 - SEC Filing

THOMSON REUTERS
·
Mar 04

Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community

GlobeNewswire
·
Mar 03